Non-covalent BTK inhibitors in CLL: activity after covalent BTK inhibitors
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-03-12
Просмотров: 4
Описание:
Romain Guièze, MD, PhD, CHU Clermont Ferrand, Clermont Ferrand, France, discusses the role of non-covalent BTK inhibitors in chronic lymphocytic leukemia (CLL), highlighting their activity in patients previously treated with covalent BTK inhibitors and their promising safety profile, while noting ongoing questions about resistance and optimal treatment sequencing. This interview took place at the ESH CLL 2026 congress in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
